Chemical Syntheses of Inulin and Levan Structures
Hz); 13C, δ 12.7, 13.3, 13.6, 13.8, 17.2, 17.3, 17.4, 49.8, 63.3,
63.5, 64.4, 70.4, 72.3, 72.6, 73.2, 73.6, 78.9, 79.7, 82.6, 84.1,
84.7, 87.7, 104.2, 109.2, 127.5-138.4. The acceptor 13 (32 mg,
33 µmol), the donor 11 (20 mg, 34 µmol), and 2,6-di-tert-butyl-
4-methylpyridine (6 mg, 34 µmol) were dissolved in CH2Cl2 (2
mL) at room temperature and under argon atmosphere.
Crushed molecular sieves (4 Å, 0.3 g) were added, and the
mixture was stirred for 10 min before DMTST (35 mg, 0.136
mmol) was added. The stirring was continued for 1 h, where-
after Et3N (0.1 mL) was added. The mixture was diluted with
CH2Cl2, filtered through Celite, and concentrated, and the
residue was purified on silica gel (toluene-EtOAc 12:1) to yield
methyl 6-O-acetyl-3-O-benzyl-1,4-O-(1,1,3,3-tetraisopropyld-
isiloxane-1,3-diyl)-â-D-fructofuranosyl-(2f6)-3-O-benzyl-1,4-O-
(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-â-D-fructofuranosyl-
(2f6)-1,3,4-tri-O-benzyl-â-D-fructofuranoside (14) (32 mg, 22
µmol, 65%). NMR: 1H, δ 0.75-0.99 (m, 56H), 1.95 (s, 3H), 3.32
(s, 3H), 3.54 (s, 2H), 3.86-3.98 (s, 7H), 4.02-4.31 (m, 11H),
4.44 (d, 1H, J ) 12.08 Hz), 4.51-4.68 (m, 7H), 4.71 (d, 1H, J
) 12.09 Hz), 4.76 (d, 1H, J ) 12.08 Hz), 4.86 (d, 1H, J ) 12.81
Hz), 7.19-7.33 (m, 25H); 13C, δ 12.6, 12.7, 13.1, 13.3, 13.6,
13.67, 13.71, 17.14, 17.17, 17.22, 17.26, 17.32, 17.39, 20.79,
49.68, 62.89, 63.31, 64.27, 65,02, 70.24, 72.52, 72.61, 72.73,
73.14, 73.56, 78.65, 79.69, 79.73, 81.99, 82.64, 84.19, 84.69,
84.85, 86.18, 103.87, 109.53, 109.79, 127.39-138.59, 170.71.
Tris(dimethylamino)sulfonium difluorotrimethylsilicate (TASF)
(0.123 mL, 1.3 M in DMF) was added to a solution of compound
14 (40 mg, 27 µmol) in DMF (1.5 mL). After stirring for 1 h
the reaction was diluted with EtOAc (50 mL) and washed with
water buffer solution (pH ) 7, 30 mL). The aqueous layer was
extracted with EtOAc (3 × 10 mL), and the combined organic
layers were dried and concentrated, and the residue was
purified by silica gel chromatography (CHCl3-MeOH 18:1) to
afford methyl 6-O-acetyl-3-O-benzyl-â-D-fructofuranosyl-(2f6)-
3-O-benzyl-â-D-fructofuranosyl-(2f6)-1,3,4-tri-O-benzyl-â-D-
fructofuranoside (15) (22 mg, 24 µmol, 81%. NMR: 1H, δ 2.05
(s, 3H), 3.32 (s, 3H), 3.36 (d, 1H), 3.46-3.60 (m, 6H), 3.73 (m,
3H), 3.87 (m, 4H), 4.05 (m, 2H), 4.17 (m, 3H), 4.29-4.43 (d,
3H), 4.46-4.58 (m, 5H), 4.61 (d, 1H, J ) 12.08 Hz), 4.67 (m,
2H), 4.75 (d, 1H, J ) 11.72 Hz), 7.19-7.39 (m, 25H); 13C, δ
20.80, 49.79, 61.79, 63.82, 63.84, 64.41, 65.36, 69.76, 72.12,
72.66, 72.74, 72.92, 73.56, 75.32, 75.38, 77.71, 79.21, 79.54,
84.21, 84.69, 84.85, 85.56, 104.09, 104.38, 104.62, 127.54-
138.20, 171.25. Sodium methoxide (3 drops, 1 M in MeOH)
was added to a solution of compound 15 (22 mg, 24 µmol) in
CH2Cl2-MeOH 1:1 (1 mL). After stirring for 1 h, the reaction
was carefully neutralized with Dowex 50 (H+) ion-exchange
resin, filtered, and concentrated. The residue was dissolved
in MeOH-EtOAc (5:1, 4 mL). Amberlite resin IR-45 (OH-)
resin (30 mg) and palladium on activated carbon were added.
The mixture was hydrogenolyzed at 110 psi overnight, filtered
twice through Celite, and concentrated. Lyophilization of the
concentrate gave methyl â-D-fructofuranosyl-(2f6)-â-D-fructo-
furanosyl-(2f6)-â-D-fructofuranoside (16) (9 mg, 17 µmol,
73%). [R]D -35 (c 0.97, CH3OH). NMR (CD3OD + 1 drop
D2O): 13C, δ 49.99, 61.51, 61.95, 62.25, 64.03, 64.48, 64.52,
76.53, 77.37, 77.62, 78.55, 78.61, 78.76, 81.72, 81.92, 83.07,
105.23, 105.50 (double intensity); 1H, δ 3.34 (s, 3H), 3.58-3.95
(15H), 4.03 (t, J ) 8 Hz, 1H), 4.04 (t, J ) 8 Hz, 1H), 4.06 (t, J
) 8 Hz, 1H), 4.14 (d, J ) 8 Hz, 1H), 4.15 (2d, J ) 8 Hz, 2H).
Anal. Calcd for C19H34O16‚3H2O: C, 39.9; H, 7.04. Found: C,
40,1; H, 7.18.
diluted with CH2Cl2, filtered through Celite, and concentrated.
The residue was purified on silica gel (toluene-EtOAc 12:1)
to afford methyl 6-O-acetyl-3-O-benzyl-1,4-O-(1,1,3,3-tetraiso-
propyldisiloxane-1,3-diyl)-â-D-fructofuranosyl-(2f1)-3,4,6-tri-
O-benzyl-â-D-fructofuranoside (17) (92 mg, 93 µmol, 86%).
NMR (CDCl3): 1H, δ 0.76-1.10 (m, 28H), 1.19 (s, 3H), 3.38 (s,
3H), 3.52 (m, 2H), 3.83-4.32 (m, 10H), 4.49-4.59 (m, 7H), 4.67
(d, 1H, J ) 12.08 Hz), 4.85 (d, 1H, J ) 12.44 Hz), 4.29 (d, 1H,
J ) 11.71 Hz), 7.18-7.37 (m, 20H); 13C, δ 12.67, 13.18, 13.59,
13.62, 17.12, 17.16, 17.19, 17.22, 17.29, 17.36, 20.81, 49.32,
62.62, 63.17, 64.95, 71.46, 72.32, 73.02, 73.12, 73.28, 78.86,
79.22, 81.99, 84.09, 85.04, 86.40, 103.94, 109.72, 127.43-
138.64, 170.71. To a solution of compound 17 (82 mg, 82 µmol)
in DMF (1.5 mL) was added TASF in DMF (1.3 M, 0.18 mL,
0.24 mmol). After stirring for 1 h, the reaction was diluted
with EtOAc (50 mL) and washed with water buffer solution
(pH ) 7, 30 mL). The aqueous layer was extracted with EtOAc
(3 × 10 mL), and the combined organic layers were dried and
concentrated, and the residue was purified by silica gel
chromatography (chloroform-MeOH 18:1) to afford methyl
6-O-acetyl-3-O-benzyl-â-D-fructofuranosyl-(2f1)-3,4,6-tri-O-
benzyl-â-D-fructofuranoside (18) (57 mg, 74 µmol, 93%). NMR
(CDCl3): 1H, δ 2.03 (s, 3H), 3.36 (s, 3H), 3.57-3.60 (m, 4H),
3.78 (s, 2H), 3.82-3.91 (m, 1H), 3.99 (m, 2H), 4.10 (m, 2H),
4.19(m, 1H), 4.26 (m, 2H), 4.51-4.61 (m, 6H), 4.75 (t, 2H),
7.20-7.32 (m, 20 H); 13C, δ 20.79, 49.96, 63.09, 64.17, 64.37,
70.82, 72.44, 72.84, 72.93, 73.29, 75.72, 78.43, 78.74, 83.55,
85.32, 85.55, 103.91, 104.18, 127.61-138.30, 171.08. 4,4’-
Dimethoxytrityl chloride (24 mg, 76 µmol) was added to a
solution of 18 (30 mg, 40 µmol) and 4-DMAP (2-4 mg, 16 µmol)
in pyridine (1.5 mL). The reaction mixture was stirred
overnight at 60 °C. MeOH (3 mL) was then added, the mixture
was concentrated and coevaporated with toluene, and the
crude product was dried overnight at reduced pressure. The
residue was dissolved in pyridine-CH2Cl2 (1:1, 4 mL) under
argon. The solution was cooled (0 °C) and benzoyl chloride (20
µL, 0.173 mmol) in CH2Cl2 (0.1 mL) was added. The mixture
was stirred for 3 h at room temperature, diluted with CH2Cl2
(20 mL), washed with aqueous saturated NaHCO3 and water,
dried, concentrated, and dried at reduced pressure. TFA (1 mL,
1% in CH2Cl2) was added dropwise to a solution of the residue
and triethylsilane (8 µL, 50 µmol) in CH2Cl2 (0.8 mL). After
20 min aqueous saturated NaHCO3 (2 mL) and then CH2Cl2
(10 mL) were added. The organic phase was separated, dried
and concentrated. The residue was purified on a silica gel
column (toluene-EtOAc 8:1) to afford methyl 6-O-acetyl-4-O-
benzoyl-3-O-benzyl-â-D-fructofuranosyl-(2f1)-3,4,6-tri-O-ben-
zy l-â-D-fructofuranoside (19) (20 mg, 24 µmol, 60% after three
steps). NMR (CDCl3): 1H, δ 2.01 (s, 3H), 3.36 (s, 3H), 3.62-
3.72 (m, 2H), 3.88-4.04 (m, 4H); 4.17-4.34 (m, 6H), 4.38-
4.60 (m, 7H), 4.67 (d, 1H, J ) 12.45 Hz), 4.74 (d, 1H, J ) 12.45
Hz), 5.59 (m, 1H), 7.19-7.99 (m, 25H); 13C, δ 20.85, 49.96,
62.90, 63.14, 65.37, 70.30, 71.84, 72.04, 72.62, 73.50, 78.69,
79.63, 81.76, 82.08, 83.78, 88.21, 103.84, 104.24, 127.58-
138.26, 162.50, 170.69. The acceptor 19 (8 mg, 9.27 µmol), the
donor 11 (5.5 mg, 9.27 µmol), and 2,6-di-tert-butyl-4-meth-
ylpyridine (1-2 mg, 9.27 µmol) were dissolved in CH2Cl2 (1
mL) together with crushed molecular sieves. The mixture was
stirred at room temperature and under argon atmosphere.
After 10 min, DMTST (20 mg, 77 µmol) was added and the
mixture was additionally stirred for 40 min and then quenched
by adding triethylamine (3-5 drops). The mixture was diluted
with CH2Cl2, filtered through Celite, and concentrated, and
the residue was purified on silica gel (toluene-EtOAc 8:1) to
yield methyl 6-O-acetyl-3-O-benzyl-1,4-O-(1,1,3,3-tetraisopro-
pyldisiloxane-1,3-diyl)-â-D-fructofuranosyl-(2f1)-6-O-acetyl-4-
O-benzoyl-3-O-benzyl-â-D-fructofuranosyl-(2f1)-3,4,6-tri-O-
benzyl-â-D-fructofuranoside (20) (8.7 mg, 6.21 µmol, 67%).
NMR (CDCl3): 1H, δ 0.97-1.08 (m, 28H), 1.97 (s, 3H), 2.00 (s,
3H), 3.35 (s, 3H), 3.47 (d, 1H, J ) 11.72 Hz), 3.55-3.75 (m,
3H), 3.89-4.06 (m, 9H), 4.18-4.37 (m, 5H), 4.38-4.46 (m, 3H),
4.47-4.60 (m, 5H), 4.65-4.87 (m, 4H), 5.61 (m, 1H), 7.29-
Meth yl 6-O-Acetyl-3-O-ben zyl-â-D-fr u ctofu r an osyl-(2f1)-
4-O-ben zoyl-3-O-ben zyl-â-D-fr u ctofu r a n osyl-(2f1)-3,4,6-
tr i-O-ben zyl-â-D-fr u ctofu r a n osid e (21). The acceptor 6 (60
mg, 0.10 mmol), the donor 11 (77 mg, 0.13 mmol) and 2,6-di-
tert-butyl-4-methylpyridine (26 mg, 0.13 mmol) were dissolved
in CH2Cl2 (2 mL) together with crushed molecular sieves (4
Å, 0.3 g). The mixture was stirred at room temperature and
under argon atmosphere for 10 min before DMTST (83 mg,
0.32 mmol) was added. The mixture was additionally stirred
for 40 min, quenched by adding triethylamine (0.15 mL),
J . Org. Chem, Vol. 67, No. 24, 2002 8461